Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NPI 1811167232
NPI deactivated

1811167232

1811167232 was paid $2.06M by Medicaid between Jan 2018 and Mar 2024, across 9 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.

33Billing provider info1811167232
33aNPI1811167232
33bProvider type—
28Total paid$2.06M
24GClaims28,988
24DCodes billed9
24AFirst – last monthJan 2018 – Mar 2024
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,212$101K
20192,052$153K
20201,216$96K
20219,407$456K
202214,973$1.21M
2024incomplete128$39K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 39% 12,753 7,969 $808K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 39% 7,128 3,149 $800K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 17% 7,329 3,452 $343K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 2.7% 561 460 $56K
H2011 Crisis intervention service, per 15 minutes 1.7% 82 19 $34K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 128 120 $12K
99205 Prolong outpt/office vis <1% 38 37 $5K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) <1% 13 13 $426.60
00000 0% 956 148 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.